Archive


Category: Applied Therapeutics

  • Applied Therapeutics slumps as FDA seeks more data on lead drug

    Shares in Applied Therapeutics slumped today after it said it would have to delay a US filing for its lead drug programme AT-007, following an FDA request for more data. The New York-based biopharma company had been hoping to file AT007 in its lead indication galactosaemia in the third quarter of last year, but said […]